Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells

Journal of Leukocyte Biology

Volumn 65, Issue 6, 1999, Pages 891-899

  Kirken, Robert A ^a   Erwin, Rebecca A ^e   Taub, Dennis ^b   Murphy, William J ^e   Behbod, Fariba ^a   Wang, Lihua ^d   Pericle, Federica ^c   Farrar, William L ^d  

^a UNIVERSITY OF TEXAS   (United States)

^b NIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e Dept of Integrative Biol and P ^*

Author keywords

Interleukin 2; Kinase inhibitors; Stats; YAKs

Indexed keywords

DNA; INTERLEUKIN 2 RECEPTOR; PROTEIN TYROSINE KINASE; TETANUS TOXOID; TYROSINE; TYRPHOSTIN;

ALLERGY; ARTICLE; AUTOIMMUNE DISEASE; CELL MATURATION; CELL PROLIFERATION; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; GENE INACTIVATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SCID MOUSE; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

JANUS;

EID: 2042503119     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.65.6.891     Document Type: Article

References (35)

1. Smith, K. A. (1988) Interleukin-2: inception, impact, and implications. Science 240, 1169-1176.
2. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K., Sugamura, K. (1993) Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262, 1874-1877.
3. Noguchi, M., Nakamura, Y., Russell, S. M., Ziegler, S. F., Tsang, M., Cao, X., Leonard, W. L. (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 262, 1877-1880.
4. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C., Miyajima, A., Puri, R. K., Paul, W. E., Leonard, W. L. (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262, 1880-1883.
5. Russell, S. M., Johnston, J. A., Noguchi, M., Kawamura, M., Bacon, C. M., Friedman, M., Berg, L. M., Witthuhn, B. A., Goldman, A. S., Schmalstieg, F. C., Ihle, J. N., O'Shea, J. J., Leonard, W. J. (1994) Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: Implications for XSCID and XCID. Science 266, 1042-1045.
6. Kirken, R. A., Rui, H., Malabarba, M. G., Howard, O. M. Z., Kawamura, M., O'Shea, J. J., Farrar, W. L. (1995) Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain. Cytokine 7, 689-700.
7. Fu, X. Y. (1992) A transcription factor with SH2 and SH3 domains is directly activated by an interferon alpha-induced cytoplasmic protein tyrosine kinase(s). Cell 70, 323-335.
8. Darnell, J. E., Jr. (1997) STATs and gene regulation. Science 277, 1630-1635.
9. c-chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett. 393, 53-56.
10. Malabarba, M. G., Rui, H., Deutsch, H. H., Chung, J., Kalthoff, F. S., Farrar, W. L., Kirken, R. A. (1996) Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha. Biochem. J. 319, 865-872.
11. O'Shea, J. J. (1997) Jaks, Stats, cytokine signal transduction, and immunoregulation-Are we there yet? Immunity 7, 1-11.
12. Thomis, T. C., Berg, L. J. (1997) The role of Jak3 in lymphoid development, activation, and signaling. Curr. Opin. Immunol. 9, 541-547.
13. Gazit, A. Yaish, P., Gilon, C., Levitzki, A. (1989) Synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32, 2344-2352.
14. Levitzki, A., Gazit, A. (1995) Tyrosine kinase inhibition: An approach to drug development. Science 267, 1782-1788.
15. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A., Roifman, C. M. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 379, 645-648.
16. Smith, M. R., Duhe, R. J., Farrar, W. L. (1997) Microinjected cDNA encoding JAK2 protein-tyrosine kinase induces DNA synthesis in NIH 3T3 cells. FEBS Lett. 408, 327-330.
17. Simon, H. U., Yousefi, S., Dibbert, B., Levischaffer, F., Blaser, K. (1997) Anti-apoptitic signals of granulocyte-macrophage colony stimulating factors are transduced via JAK2 tyrosine kinase in eosinophils. Eur. J. Immunol. 27, 3536-3539.
18. McWhinney, C. D., Hunt, R. A., Conrad, K. M., Dostal, D. E., Baker, K. M. (1997) The type I angiotensin II receptor couples to STAT1 and STAT3 activation through JAK2 kinase in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. 29, 2513-2524.
19. Marrero, M. B., Schieffer B., Li, B., Sun, J. M., Harp, J. B., Ling, B. N. (1997) Role of Janus kinase signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II-and Platelet-Derived Growth Factor-induced vascular smooth muscle cell proliferation. J. Biol. Chem. 272, 24684-24690.
20. Pericle, F., Kirken, R. A., Bronte, V., Sconocchia, G., DaSilva, L., Segal, D. M. (1997) Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes. J. Immunol. 159, 2580-2585.
21. Kirken, R. A., Malabarba, M. G., Xu, J., DaSilva, L., Erwin, R. A., Liu, X., Hennighausen, L., Rui, H., Farrar, W. L. (1997) Two discrete regions of interleukin-2 (IL-2) receptor-β independently mediate IL-2 activation of a PD98059/rapamycin/wortmannin insensitive STAT5a/b serine kinase. J. Biol. Chem. 272, 15459-15465.
22. Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yin, T., Tang, B., Miura, O., Ihle, J. N. (1993) JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74, 227-236.
23. Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., Carter-Su, C. (1993) Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
24. Rui, H., Kirken, R. A., Farrar, W. L. (1994) Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269, 5364-5368.
25. Malabarba, M. G., Kirken, R. A., Rui, H., Koettnitz, K., Kawamura, M., O'Shea, J. J., Kalthoff, F.S., Farrar, W. L. (1995) Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha. J. Biol. Chem. 270, 9630-9637.
26. Oakes, S. A., Candotti, F., Johnston, J. A., Chen, Y. Q., Ryan, J. J., Taylor, N., Liu, X., Hennighausen, L., Notarangelo, L. D., Paul, W. E., Blaese, R. M., O'Shea, J. J. (1996) Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes. JAK3-dependent and independent pathways. Immunity 5, 605-615.
27. Higuchi, M., Asao, H., Tanaka, N., Oda, K., Takeshita, T., Nakamura, M., Van-Snick, J., Sugamura, K. (1996) Dispensability of Jak1 tyrosine kinase for interleukin-2-induced cell growth signaling in a human T cell line. Eur. J. Immunol. 6, 1322-1327.
28. Durbin, J. E., Hackenmiller, R., Simon, M. C., Levy, D. E. (1996) Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84, 443-450.
29. Meraz, M. A., White, J. M., Sheehan, K. C., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., Carver-Moore, K., DuBois, R. N., Clark, R., Aguet, M., Schreiber, R. D. (1996) Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84, 431-442.
30. Thierfelder, W. E., van-Deursen, J. M., Yamamoto, K., Tripp, R. A., Sarawar, S. R., Carson, R. T., Sangster, M. Y., Vignali, D. A., Doherty, P. C., Grosveld, G. C., Ihle, J. N. (1996) Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382, 171-174.
31. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A., Doherty, P. C., Grosveld, G., Paul, W. E., Ihle, J. N. (1996) Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
32. Liu, X., Robinson, G. W., Gouilleux, F., Groner, B., Hennighausen, L. (1995) Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA 92, 8831-8835.
33. Udy, G. B., Towers, R. P., Snell, R. G., Wilkins, R. J., Park, S. H., Ram, P. A., Waxman, D. J., Davey, H. W. (1997) Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc. Natl. Acad. Sci. USA 94, 7239-7244.
34. Pericle, F., Pinto, L. A., Hicks, S., Kirken, R. A., Sconocchia, G., Rusnak, J., Dolan, M. J., Shearer, G. M., Segal, D. M. (1998) HIV-1 infection induces a selective reduction in STAT5 protein expression. J. Immunol. 160, 28-32.
35. Taub, D. D., Murphy, W. J., Asai, O., Fenton, R. G., Peltz, G., Key, M. L., Turcovski-Corrales. S., Longo, D. L. (1997) Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin. J. Immunol 158, 2745-2755.